GB202004679D0 - Modified latercy associated protein construct - Google Patents
Modified latercy associated protein constructInfo
- Publication number
- GB202004679D0 GB202004679D0 GBGB2004679.3A GB202004679A GB202004679D0 GB 202004679 D0 GB202004679 D0 GB 202004679D0 GB 202004679 A GB202004679 A GB 202004679A GB 202004679 D0 GB202004679 D0 GB 202004679D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- latercy
- modified
- associated protein
- protein construct
- construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2004679.3A GB202004679D0 (en) | 2020-03-31 | 2020-03-31 | Modified latercy associated protein construct |
PCT/EP2021/058418 WO2021198324A1 (en) | 2020-03-31 | 2021-03-31 | Modified latency associated protein construct |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2004679.3A GB202004679D0 (en) | 2020-03-31 | 2020-03-31 | Modified latercy associated protein construct |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202004679D0 true GB202004679D0 (en) | 2020-05-13 |
Family
ID=70553314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2004679.3A Ceased GB202004679D0 (en) | 2020-03-31 | 2020-03-31 | Modified latercy associated protein construct |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202004679D0 (en) |
WO (1) | WO2021198324A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284763A (en) | 1985-03-22 | 1994-02-08 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
US5697901A (en) | 1989-12-14 | 1997-12-16 | Elof Eriksson | Gene delivery by microneedle injection |
US5824647A (en) * | 1990-12-12 | 1998-10-20 | Postlethwaite; Arnold E. | Chemotactic wound healing peptides |
US6942853B2 (en) | 2001-01-09 | 2005-09-13 | Queen Mary And Westfield College | Latent fusion protein |
GB0724556D0 (en) | 2007-12-17 | 2008-01-30 | Queen Mary & Westfield College | LAtency associated protein construct with aggrecanase sensitive cleavage site |
GB201411506D0 (en) | 2014-06-27 | 2014-08-13 | Univ London Queen Mary | Modified latency associated protein construct |
-
2020
- 2020-03-31 GB GBGB2004679.3A patent/GB202004679D0/en not_active Ceased
-
2021
- 2021-03-31 WO PCT/EP2021/058418 patent/WO2021198324A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021198324A1 (en) | 2021-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL281804A (en) | Protein purification methods | |
ZA202100859B (en) | Recombinant protein variants | |
DK3737402T3 (en) | Modificeret protein | |
GB201917046D0 (en) | Improved protein production | |
GB202007441D0 (en) | Polypeptide | |
EP4083055A4 (en) | Sugar-modified protein | |
GB202017649D0 (en) | Polypeptide | |
GB202005876D0 (en) | Protein degradation | |
ZA202003722B (en) | Modified globin proteins | |
EP3724212A4 (en) | Crm197 protein expression | |
GB202004679D0 (en) | Modified latercy associated protein construct | |
EP3987028A4 (en) | Engineered oncoselective protein expression | |
EP3976630A4 (en) | Actrii-binding proteins and uses thereof | |
GB202101826D0 (en) | Protein | |
GB202101828D0 (en) | Protein | |
GB202101825D0 (en) | Protein | |
GB201817485D0 (en) | Protein tablets | |
GB202117583D0 (en) | Protein expression | |
GB202115803D0 (en) | Novel proteins | |
GB202301933D0 (en) | Protein | |
GB202301919D0 (en) | Protein | |
GB202017506D0 (en) | Novel proteins | |
GB202201715D0 (en) | Protein | |
GB202201714D0 (en) | Protein | |
GB202312969D0 (en) | Modified proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |